Transcriptomics

Dataset Information

0

Enzalutamide resistance in prostate cancer cells


ABSTRACT: Castration resistant prostate cancer (CRPC) develops resistance to antiandrogens affecting Androgen Receptor (AR) signaling through a variety of mechanism. Because of this, the efficacy of androgen receptor targeted therapy remains limited for many patients with CRPC. We developed LNCaP-enzalutamide (ENZU) and resistance cells to study changes in transcriptomic profile compared to parental cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE150807 | GEO | 2020/12/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-12-31 | GSE151083 | GEO
2016-06-10 | E-GEOD-69896 | biostudies-arrayexpress
2018-08-01 | GSE88752 | GEO
2013-04-01 | E-GEOD-44905 | biostudies-arrayexpress
2023-01-01 | GSE220467 | GEO
2016-06-10 | GSE69896 | GEO
2013-04-01 | GSE44905 | GEO
2024-02-28 | GSE258991 | GEO
2022-05-12 | GSE202755 | GEO
2018-12-26 | GSE109708 | GEO